Cargando…

A retrospective pooled analysis of response patterns and risk factors in recurrent malignant glioma patients receiving a nitrosourea-based chemotherapy

BACKGROUND: At recurrence the use of nitrosoureas is widely-used as a therapeutic option for glioblastoma (GBM) patients. The efficacy of fotemustine (FTM) has been demonstrated in phase II clinical trials; however, these papers report a wide range of progression-free-survival (PFS-6 m) rates, rangi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paccapelo, Alessandro, Lolli, Ivan, Fabrini, Maria Grazia, Silvano, Giovanni, Detti, Beatrice, Perrone, Franco, Savio, Giuseppina, Santoni, Matteo, Bonizzoni, Erminio, Perrone, Tania, Scoccianti, Silvia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3412703/ https://www.ncbi.nlm.nih.gov/pubmed/22583678 http://dx.doi.org/10.1186/1479-5876-10-90

Ejemplares similares

Efficacy and safety of second-line fotemustine in elderly patients with recurrent glioblastoma
por: Santoni, Matteo, et al.
Publicado: (2013)

Palonosetron plus single-dose dexamethasone for the prevention of nausea and vomiting in women receiving anthracycline/cyclophosphamide-containing chemotherapy: meta-analysis of individual patient data examining the effect of age on outcome in two phase III trials
por: Celio, Luigi, et al.
Publicado: (2012)

Feasibility and safety of a reduced duration of therapy of colony-stimulating factor in a dose-dense regimen
por: Rigacci, Luigi, et al.
Publicado: (2014)

Pharmacokinetic study between a bilayer matrix fentalyl patch and a monolayer matrix fentanyl patch: single dose administration in healthy volunteers*
por: Zecca, Ernesto, et al.
Publicado: (2015)

Chemotherapy-associated thromboembolic risk in cancer outpatients and effect of nadroparin thromboprophylaxis: results of a retrospective analysis of the PROTECHT study
por: Barni, Sandro, et al.
Publicado: (2011)

Cost-utility and budget impact analyses of the use of NEPA for chemotherapy-induced nausea and vomiting prophylaxis in Italy
por: Restelli, Umberto, et al.
Publicado: (2017)

Bevacizumab in recurrent high-grade glioma: a single institution retrospective analysis on 92 patients
por: Detti, Beatrice, et al.
Publicado: (2021)

Fotemustine: A Third-Generation Nitrosourea for the Treatment of Recurrent Malignant Gliomas
por: Beauchesne, Patrick
Publicado: (2012)

Acute and late vaginal toxicity after adjuvant high-dose-rate vaginal brachytherapy in patients with intermediate risk endometrial cancer: is local therapy with hyaluronic acid of clinical benefit?
por: Laliscia, Concetta, et al.
Publicado: (2016)

Lenograstim and filgrastim in the febrile neutropenia prophylaxis of hospitalized patients: efficacy and cost of the prophylaxis in a retrospective survey
por: Innocenti, Rolando, et al.
Publicado: (2018)

A multimodal approach to the treatment of bilateral choroidal metastases from thyroid carcinoma
por: Fabrini, Maria Grazia, et al.
Publicado: (2009)

Non-melanoma skin cancer treated with high-dose-rate brachytherapy and Valencia applicator in elderly patients: a retrospective case series
por: Delishaj, Durim, et al.
Publicado: (2015)

An overview of published results from randomized studies of nitrosoureas in primary high grade malignant glioma.
por: Stenning, S. P., et al.
Publicado: (1987)

[(11)C]-Methionine Positron Emission Tomography in the Postoperative Imaging and Followup of Patients with Primary and Recurrent Gliomas
por: Santoni, Matteo, et al.
Publicado: (2014)

Hypoxic cells and in situ chemopotentiation of the nitrosoureas by misonidazole.
por: Wheeler, K. T., et al.
Publicado: (1984)

Proceedings: Mechanism of action of tumour inhibitory nitrosoureas.
por: Connors, T. A., et al.
Publicado: (1975)

Histologic Distribution and Characteristics on MR Imaging of Ultrasmall Superparamagnetic Iron Oxide in Ethyl-nitrosourea-induced Endogenous Rat Glioma
por: Yamamoto, Atsuko, et al.
Publicado: (2020)

Antiemetic efficacy of single-dose palonosetron and dexamethasone in patients receiving multiple cycles of multiple day-based chemotherapy
por: Lorusso, Vito, et al.
Publicado: (2012)

A Comparative Study of Survival Rate in High Grade Glioma Tumors Being Treated by Radiotherapy Alone Versus Chemoradiation With Nitrosourea
por: Houshyari, Mohammad, et al.
Publicado: (2015)

Proceedings: Histology of tumour formation in the bladder of rats receiving dietary saccharin and a single dose of N-methyl N-nitrosourea.
por: Chowaniec, A. J., et al.
Publicado: (1974)

Olive Mill Wastewater Fermented with Microbial Pools as a New Potential Functional Beverage
por: Foti, Paola, et al.
Publicado: (2023)

Long-Term Efficacy of Safinamide on Symptoms Severity and Quality of Life in Fluctuating Parkinson’s Disease Patients
por: Cattaneo, Carlo, et al.
Publicado: (2020)

Enhancement of nitrosourea cytotoxicity by misonidazole in vitro: correlation with carbamoylating potential.
por: Mulcahy, R. T., et al.
Publicado: (1984)

Monocentric Analysis of the Effectiveness and Financial Consequences of the Use of Lenograstim versus Filgrastim for Mobilization of Peripheral Blood Progenitor Cells in Patients with Lymphoma and Myeloma Receiving Chemotherapy and Autologous Stem Cell Transplantation
por: Restelli, Umberto, et al.
Publicado: (2020)

The Burden of Structured Self-Monitoring of Blood Glucose on Diabetes-Specific Quality of Life and Locus of Control in Patients with Noninsulin-Treated Type 2 Diabetes: The PRISMA Study
por: Russo, Giuseppina T., et al.
Publicado: (2016)

Effects of Safinamide on Pain in Fluctuating Parkinson’s Disease Patients: A Post-Hoc Analysis
por: Cattaneo, Carlo, et al.
Publicado: (2017)

Activity of a new nitrosourea (TCNU) in human lung cancer xenografts.
por: Fergusson, R. J., et al.
Publicado: (1988)

Experimental induction of ovarian Sertoli cell tumors in rats by N-nitrosoureas.
por: Maekawa, A, et al.
Publicado: (1987)

Studies on N-Ethyl-N-nitrosourea Mutagenesis in BALB/c Mice
por: Cho, Kyu-Hyuk, et al.
Publicado: (2008)

Long-Term Effects of Safinamide on Dyskinesia in Mid- to Late-Stage Parkinson’s Disease: A Post-Hoc Analysis
por: Cattaneo, Carlo, et al.
Publicado: (2015)

DIPG-27. DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) CHALLENGE: FROM GENE EXPRESSION PROFILE TO DRUG
por: Scilimati, Antonio, et al.
Publicado: (2023)

Over-representation of specific regions of chromosome 22 in cells from human glioma correlate with resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea
por: Hank, Nicole C, et al.
Publicado: (2006)

Macronutrient content of pooled donor human milk before and after Holder pasteurization
por: Piemontese, Pasqua, et al.
Publicado: (2019)

Preventive effect of Oenothera rosea on N-methyl-N-nitrosourea-(NMU) induced gastric cancer in rats
por: Almora-Pinedo, Yuan, et al.
Publicado: (2017)

Receptor-Drug Interaction: Europium Employment for Studying the Biochemical Pathway of G-Protein-Coupled Receptor Activation
por: Antonio, Colabufo Nicola, et al.
Publicado: (2007)

Proceedings: Toxic effect of N-methyl-N-nitrosourea on normal and transformed cells.
por: Wilkinson, R., et al.
Publicado: (1974)

The multipotential carcinogenic action of N-ethyl-N-nitrosourea administered neonatally to mice.
por: Searle, C. E., et al.
Publicado: (1976)

4-Hydroxyandrostenedione in the prophylaxis of N-methyl-N-nitrosourea induced mammary tumourigenesis.
por: Coombes, R. C., et al.
Publicado: (1991)

N -Ethyl- N -Nitrosourea Induces Retinal Photoreceptor Damage in Adult Rats
por: Yoshizawa, Katsuhiko, et al.
Publicado: (2012)

Nimodipine inhibits N-methyl-N-nitrosourea-induced retinalphotoreceptor apoptosis in vivo
por: Wang, Dan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_a5ntsq47sthaa6d4rps0ai9c7p